3 ASX Growth Companies With Insider Ownership Up To 37% [Yahoo! Finance]
Mesoblast Limited - American Depositary Shares (MESO)
US:NASDAQ Investor Relations:
investorsmedia.mesoblast.com
Company Research
Source: Yahoo! Finance
Top 10 Growth Companies With High Insider Ownership In Australia Name Insider Ownership Earnings Growth Clinuvel Pharmaceuticals (ASX:CUV) Genmin (ASX:GEN) Catalyst Metals (ASX:CYL) Hillgrove Resources (ASX:HGO) AVA Risk Group (ASX:AVA) Pointerra (ASX:3DP) Liontown Resources (ASX:LTR) Acrux (ASX:ACR) Adveritas (ASX:AV1) Plenti Group (ASX:PLT) Let's dive into some prime choices out of the screener. Simply Wall St Growth Rating: ?????? Overview: Mesoblast Limited is involved in the development of regenerative medicine products across Australia, the United States, Singapore, and Switzerland, with a market cap of A$1.59 billion. Operations: The company's revenue is primarily derived from the development of its cell technology platform for commercialization, totaling $5.90 million. Insider Ownership: Mesoblast is poised for significant growth with its high insider ownership, despite recent financial challenges. The company anticipates becoming profita
Show less
Read more
Impact Snapshot
Event Time:
MESO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MESO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MESO alerts
High impacting Mesoblast Limited - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
MESO
News
- Ryoncil® FDA Approval and Market Launch Highlighted at Tandem Transplantation Meetings [Yahoo! Finance]Yahoo! Finance
- Ryoncil® FDA Approval and Market Launch Highlighted at Tandem Transplantation MeetingsGlobeNewswire
- Mesoblast Limited (NASDAQ: MESO) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $24.00 price target on the stock, up previously from $15.00.MarketBeat
- Mesoblast Limited (NASDAQ: MESO) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.MarketBeat
- Ryoncil® Commercial Launch Update and Product PipelineGlobeNewswire